Open house Arzneimittelrabattverträge zum Wirkstoff Naproxen, ATC M01AE02

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund offers discount contracts with the aforementioned active ingredient to all interested pharmaceutical companies without selection decision. The contracts are concluded within the framework of an "Open House Model." The contracts offered are non-exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund. Uniform conditions apply to all participants in the Open House model. Contract contents, terms and access procedures are uniform - individual negotiations are not conducted. Contract durations are a maximum of 24 months, with the earliest contract start date being 01.10.2026. All contracts end at the latest 24 months after the day of the earliest contract start date, regardless of the date of the respective contract conclusion. Entry or contract conclusion can take place within the 24-month period on the first day of each month. There is a right of termination with notice of 6 weeks to the end of the month in accordance with the provisions of the contract. Further information on termination options is included in the contract documents.…

TENDER BRIEF

TENDER DOCUMENTS